Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 46 citing Kimmel: Oral agents for type 2 diabetes: an update. (0.09 sec) 

Diabetes mellitus and periodontal diseases

- perioimplantelsalvador.com [PDF] 
BL Mealey, TW Oates - Journal of Periodontology, 2006 - Am Acad Periodontology
Background: The purpose of this review is to provide the reader with practical
knowledge concerning the relationship between diabetes mellitus and periodontal
diseases. Over 200 articles have been published in the English literature ...
Cited by 160 - Related articles - BL Direct - All 18 versions

Diabetes mellitus and heart failure: epidemiology, mechanisms, and pharmacotherapy


FA Masoudi, SE Inzucchi - The American Journal of Cardiology, 2007 - Elsevier
Several studies have established a strong and independent relation between
diabetes and the risk for HF. Early data from the Framingham cohort suggested an
association between diabetes and the risk for incident HF independent of ...
Cited by 30 - Related articles - All 28 versions

Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with …

- mt.gov [PDF] 
J Rosenstock, J Rood, A Cobitz, N Biswas, H … - Diabetes Obes Metab, 2006 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Cited by 31 - Related articles - All 6 versions

Progress in the treatment of type 2 diabetes: new pharmacologic approaches to improve …


A Cohen, ES Horton - Current Medical Research and Opinion®, 2007 - informahealthcare.com
Background: Type 2 diabetes mellitus (T2DM) is a leading cause of morbidity and
mortality that places a substantial economic and health burden on the public.
Successful management of T2DM requires strict control of glycemia as well ...
Cited by 26 - Related articles - BL Direct - All 5 versions

Glycemic response to newly initiated diabetes therapies


AJ Karter, HH Moffet, J Liu, MM Parker, AT … - The American journal of managed care, 2007 - pubmedcentral.nih.gov
Authorship Information: Concept and design (AJK, HHM, ATA); acquisition of data
(AJK, JL, MMP, JVS); analysis and interpretation of data (AJK, JL, MMP, ATA,
ASG, JVS); drafting of the manuscript (AJK, HHM); critical revision of the ...
Cited by 12 - Related articles - BL Direct - All 5 versions

Modeling and informatics in designing anti-diabetic agents


PV Bharatam, DS Patel, L Adane, A Mittal, S … - Current pharmaceutical design, 2007 - ingentaconnect.com
Abstract: Diabetes mellitus is a chronic metabolic disorder, characterized by
glucose overproduction and glucose underutilization. Cur- rent therapy for T2DM
includes drugs, like metformin, glitazones, sulphonyl ureas, etc. Extensive ...
Cited by 7 - Related articles - BL Direct - All 3 versions

Trends in the use of oral antidiabetic drugs by outpatients in Taiwan: 1997-2003


CW Chiang, HF Chiu, CY Chen, HL Wu, CY … - Journal of Clinical Pharmacy and Therapeutics, 2006 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Cited by 5 - Related articles - BL Direct - All 4 versions

[PDF] Management of blood glucose in type 2 diabetes mellitus


CM RIPSIN, J URBAN - MANAGEMENT - findlay.edu
Evidence-based guidelines for the treatment of type 2 diabetes mellitus focus on
three areas: intensive lifestyle inter- vention that includes at least ISO
minutes per week of physical activity, weight loss with an initial goal of7 ...
Cited by 5 - Related articles - View as HTML - All 5 versions

Management of type 2 diabetes in the obese patient: current concerns and emerging …


AJ Krentz - Current Medical Research and Opinion®, 2007 - informahealthcare.com
0300-7995 doi:10.1185/030079907X219661 All rights reserved: reproduction in
whole or part not permitted ... CURREnt MEdICAL REsEARCh And OPInIOn® VOL. 24,
NO. 2, 2008, 401–417 © 2008 LIbRAPhARM LIMItEd
Cited by 4 - Related articles - BL Direct - All 5 versions

Cost effectiveness of duloxetine in the treatment of diabetic peripheral neuropathic pain in …


SM Beard, L McCrink, TK Le, A Garcia- … - Current Medical Research and Opinion®, 2007 - informahealthcare.com
Objective: The objective of this analysis was to evaluate the cost-effectiveness
of duloxetine when considered as an additional treatment option for UK-based
patients suffering from diabetic peripheral neuropathic pain. Research ...
Cited by 2 - Related articles - BL Direct - All 6 versions


Result Page: 

1

2

3

4

5

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google